Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland
NCT ID: NCT05232786
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1152 participants
OBSERVATIONAL
2022-03-08
2022-04-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland
NCT05795166
Multinational Point Prevalence Study on the Management of Diabesity in Hospitals
NCT06680674
Fertility and Cardiovascular Risk in Men With Metabolic Syndrome
NCT03977064
Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome
NCT03047655
Personalised Advice for the Prevention of Metabolic Syndrome
NCT04595669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
People / Person Living with Obesity (PLwO)
From online, general population consumer panels
No treatment given
No treatment given
Health Care Professionals (HCPs)
HCPs treating people who have obesity
No treatment given
No treatment given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No treatment given
No treatment given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male, female or other, aged above or equal to 18 years at the time of signing informed consent
3. Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)
4. Current BMI of 30 Kg/m\^2 or greater calculated based on self-reported height and weight
Health Care Professionals:
1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
2. Male, female or other, aged above or equal to 18 years at the time of signing informed consent.
3. Physician
4. Dietitian who is a member of the SVDE ASDD (Swiss Association of Dietitians) and services covered by the compulsory health insurance
5. Primary Care Providers (PCPs) whose specialty is Family Practice, General Practice, General Internal Medicine (who is focused on primary care)
6. Non-PCP Specialties whose specialty is Obstetrics/Gynaecologists, Endocrinologists/Diabetologists. Psychiatrists, General Internal Medicine with focus on diabetes and/or obesity and bariatric surgeons who are involved in the management of obesity in addition to surgery
7. Practices in Switzerland
8. In clinical practice for greater than or equal to 2 years
9. Spends at least 50% time in direct patient care
10. Has seen at least 100 adult patients in past month (all physicians except psychiatrists) Has seen at least 10 patients with obesity (PCPs and General Internal Medicine with focus on Diabetes and/or obesity, Obstetrics/ Gynaecologists, Endocrinology/Diabetology or Bariatric surgery) or 5 patients with obesity (dietitians and psychiatrists) in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 Kg/m\^2 with or without comorbidities.
Exclusion Criteria
1. Previous participation in this study. Participation is defined as having given online consent in this study
2. Currently pregnant
3. Participates in intense fitness or body building programs
4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Health Care Providers:
1. Previous participation in this study. Participation is defined as having given informed consent in this study.
2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novo Nordisk A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Transparency (dept. 2834)
Role: STUDY_DIRECTOR
Novo Nordisk A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novo Nordisk Investigational Site
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1266-4398
Identifier Type: OTHER
Identifier Source: secondary_id
DAS-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.